ENANTA PHARMACEUTICALS INC (ENTA) › Total AssetsENANTA PHARMACEUTICALS INC (ENTA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2012: $52.16M2013: $116.97M2014: $155.41M2015: $246.01M2016: $281.28M2017: $326.64M2018: $414.23M2019: $489.83M2020: $486.13M2021: $438.79M2022: $375.41M2023: $462.27M2024: $376.65M2025: $280.73M$280.73M2012Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$280.73M-25.5%2024$376.65M-18.5%2023$462.27M+23.1%2022$375.41M-14.4%2021$438.79M-9.7%2020$486.13M-0.8%2019$489.83M+18.3%2018$414.23M+26.8%2017$326.64M+16.1%2016$281.28M+14.3%2015$246.01M+58.3%2014$155.41M+32.9%2013$116.97M+124.2%2012$52.16M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share